Commentary

Beyond DSM symptoms: Behavioral clues to diagnosing bipolar II disorder

Author and Disclosure Information

 

References

The above behaviors are condensed in a list that Dr. Akiskal called “the rule of 3” in patients with depression (Table1). Not all patients with bipolar II disorder will meet all the criteria of the rule of 3, but the first item in the mental status exam (appearance) alone may reflect the “soft bipolar spectrum,” such as garish clothing, red sneakers, multiple rings, bizarre hair coloring, and multiple piercings. This might prompt the clinician to ask further questions about hypomanic episodes as well as other personal behaviors related to the rule of 3.

Dr. Akiskal’s rule of 3: Differentiating bipolar II disorder from MDD

Dr. Akiskal’s contributions to psychiatry are legendary in their originality, creativity, and clinical relevance. The rule of 3 is but one of his clinical concepts that may help identify many individuals with bipolar II disorder who are misdiagnosed as having MDD and prescribed a treatment that does not help or may exacerbate their illness course and worsen their outcome.

Based on the referrals of patients who are “treatment-resistant” to our Resident Mood Clinic, there are numerous persons in the country with bipolar II disorder (possibly millions) who are mislabeled with MDD and receiving the wrong treatments, to which they failed to respond. Their lifestyles and behaviors can provide valuable clinical insights into their true psychopathology, and that will lead to developing the right treatment plan.

Pages

Recommended Reading

‘Remarkable’ response to diabetes drug in resistant bipolar depression
MDedge Psychiatry
How a community-based program for SMI pivoted during the pandemic
MDedge Psychiatry
Mood stabilizers: Balancing tolerability, serum levels, and dosage
MDedge Psychiatry
Stuck in a rut with the wrong diagnosis
MDedge Psychiatry
Britney Spears and her 13-year conservatorship: An abuse of involuntary care?
MDedge Psychiatry
Psychiatric genomics has a diversity problem
MDedge Psychiatry
Ketamine and psychosis risk: New data
MDedge Psychiatry
Let’s talk about race
MDedge Psychiatry
Obesity treatment in mental illness: Is semaglutide a game changer?
MDedge Psychiatry
‘Reassuring’ findings for second-generation antipsychotics during pregnancy 
MDedge Psychiatry